A Study to Test Combination Treatments in People With Advanced Renal Cell Carcinoma

NCT02996110 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

182

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Cancer

Interventions

BIOLOGICAL: Nivolumab
BIOLOGICAL: Ipilimumab
BIOLOGICAL: Relatlimab
DRUG: BMS-986205
DRUG: BMS-813160

Sponsor

Bristol-Myers Squibb